POU4F3 Plus Keratin AE1/AE3 or Pan-keratin: An Optimal Sentinel Lymph Node Protocol for Merkel Cell Carcinoma
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2025.100949 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Modern Pathology, 2026. Verfasst von Diogo Maia-Silva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Biomarkers, Tumor, Skin Neoplasms, Sentinel Lymph Node. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Massachusetts General Hospital.
Abstract (Originalsprache)
There is currently no standardized sentinel lymph node (SLN) immunohistochemistry (IHC) protocol for detecting Merkel cell carcinoma (MCC) metastases. A cost-effective, high-sensitivity panel could improve diagnostic accuracy and resource utilization. We evaluated 226 SLNs from 81 MCC patients using a panel of POU4F3, keratin 20, and keratin AE1/AE3 or pan-keratin. Metastasis was defined as positive staining for any of the tested IHC markers. Patients' age ranged from 49 to 92 years (median, 73.5 years), with a male:female ratio of 1.8:1. Primary tumor sites were extremities (48.1%), head/neck (34.6%), and trunk (17.3%). SLN locations included cervical (29.6%), axillary (27%), femoral (20.8%), inguinal (9.7%), facial (7.1%), pelvic (3.1%), and epitrochlear (2.7%) sites. Metastases were identified in 102 of 226 SLNs (45%). Single-marker sensitivities were POU4F3 (96%, 98/102), keratin 20 (67%, 68/102), and keratin AE1/AE3 or pan-keratin (64%, 70/102). The most sensitive combinations were POU4F3 with keratin AE1/AE3 or pan-keratin (100% sensitivity) or POU4F3 with keratin 20 (98% sensitivity). Keratin 20 with keratin AE1/AE3 or pan-keratin was the least sensitive (74%). In 6 patients (7.4%), POU4F3 detected single metastatic cells in SLNs that were previously diagnosed at time of clinical diagnosis as negative by keratin 20 and keratin AE1/AE3 or pan-keratin panel. POU4F3 is the most sensitive individual IHC marker for detecting MCC SLN metastases. The optimal cost-effective panel is POU4F3 with keratin AE1/AE3 or pan-keratin, which achieves 100% sensitivity while reducing reliance on less effective stains. Adoption of this focused IHC panel may serve to standardize SLN evaluation for MCC and improve diagnostic accuracy and efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.
- Department of Pathology, Brigham Women's Hospital, Boston, Massachusetts; Department of Pathology, Harvard Medical School, Boston, Massachusetts.
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; Department of Pathology, Harvard Medical School, Boston, Massachusetts. Electronic address: mhoang@mgh.harvard.edu.
Förderung
- Massachusetts General Hospital
Zitieren
APA
Maia-Silva, D., DeSimone, M. S., Shore, K. T., & Hoang, M. P. (2026). POU4F3 Plus Keratin AE1/AE3 or Pan-keratin: An Optimal Sentinel Lymph Node Protocol for Merkel Cell Carcinoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100949
Vancouver
Maia-Silva D, DeSimone MS, Shore KT, Hoang MP. POU4F3 Plus Keratin AE1/AE3 or Pan-keratin: An Optimal Sentinel Lymph Node Protocol for Merkel Cell Carcinoma. Modern Pathology. 2026. doi:10.1016/j.modpat.2025.100949
BibTeX
@article{MaiaSilva2026,
author = {Maia-Silva, Diogo and DeSimone, Mia S and Shore, Karen T and Hoang, Mai P},
title = {POU4F3 Plus Keratin AE1/AE3 or Pan-keratin: An Optimal Sentinel Lymph Node Protocol for Merkel Cell Carcinoma},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2025.100949}
}
EUVIMED